ID
21514
Beskrivning
HD16 NCT Nr.: NCT00736320 HD16 for Early Stages - Treatment Optimization Trial in the First-line Treatment of Early Stage Hodgkin Lymphoma; Treatment Stratification by Means of FDG-PET. This study is designed to test the non-inferiority of the experimental arm compared to the standard arm in terms of Progression free survival (PFS). HD17 NCT Nr.: NCT01356680 HD17 for Intermediate Stages - Treatment Optimization Trial in the First-Line Treatment of Intermediate Stage Hodgkin Lymphoma.This study is designed to test the non-inferiority of the experimental arm compared to the standard arm in terms of progression free survival (PFS). HD18 NCT Nr.: NCT00515554 HD18 for Advanced Stages in Hodgkins Lymphoma. This study is designed to test: in patients with negative positron-emission tomography (PET) after 2 cycles of BEACOPPesc chemotherapy: whether the number of cycles can be reduced without compromising progression free survival (PFS) (2 further cycles vs. 6 further cycles) for patients with positive PET after 2 cycles: whether intensifying BEACOPPesc chemotherapy by adding Rituximab improves PFS. Permission granted by: Andreas Engert, M.D. Chairman, German Hodgkin Study Group Professor for Internal Medicine Hematology & Oncology University Hospital of Cologne Department of Internal Medicine I Kerpener Str. 62 D-50924 Köln Phone: +49-221-478-5933/5966 Fax: +49-221-478-3778 a.engert@uni-koeln.de
Nyckelord
Versioner (5)
- 2017-04-24 2017-04-24 -
- 2017-04-25 2017-04-25 -
- 2017-05-03 2017-05-03 -
- 2018-11-14 2018-11-14 - Sarah Riepenhausen
- 2021-03-15 2021-03-15 - Dr. rer. medic Philipp Neuhaus
Uppladdad den
25 april 2017
DOI
För en begäran logga in.
Licens
Creative Commons BY-NC 3.0
Modellkommentarer :
Här kan du kommentera modellen. Med hjälp av pratbubblor i Item-grupperna och Item kan du lägga in specifika kommentarer.
Itemgroup-kommentar för :
Item-kommentar för :
Du måste vara inloggad för att kunna ladda ner formulär. Var vänlig logga in eller registrera dig utan kostnad.
German Hodgkin Study Group Study HD16/HD17/HD18 Treatment discontinuation form G6AB
Deutsche Hodgkin Studiengruppe: G6AB Therapieabbruchbogen
- StudyEvent: ODM
Beskrivning
Therapieabbruchbogen
Beskrivning
Date of discontinuation
Datatyp
date
Alias
- UMLS CUI [1,1]
- C0457454
- UMLS CUI [1,2]
- C0011008
Beskrivning
Reason for discontinuation
Datatyp
integer
Alias
- UMLS CUI [1,1]
- C0566251
- UMLS CUI [1,2]
- C0457454
Beskrivning
Treatment status
Datatyp
integer
Alias
- UMLS CUI [1]
- C0749659
Beskrivning
Further documentation
Datatyp
text
Alias
- UMLS CUI [1]
- C0175636
Beskrivning
Date of completion
Datatyp
date
Alias
- UMLS CUI [1]
- C0011008
Beskrivning
Signature
Datatyp
text
Alias
- UMLS CUI [1]
- C1519316
Similar models
Deutsche Hodgkin Studiengruppe: G6AB Therapieabbruchbogen
- StudyEvent: ODM
C1515258 (UMLS CUI [1,2])
C0600091 (UMLS CUI [1,2])
C0600091 (UMLS CUI [1,2])
C0011008 (UMLS CUI [1,2])
C0457454 (UMLS CUI [1,2])